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Abstract
Background: Syndesmotic injuries are common and their incidence is rising. In case of surgical fixation of the
syndesmosis a metal syndesmotic screw is used most often. It is however unclear whether this screw needs to be
removed routinely after the syndesmosis has healed. Traditionally the screw is removed after six to 12 weeks as it is
thought to hamper ankle functional and to be a source of pain. Some studies however suggest this is only the case
in a minority of patients. We therefore aim to investigate the effect of retaining the syndesmotic screw on
functional outcome.
Design: This is a pragmatic international multicentre randomised controlled trial in patients with an acute
syndesmotic injury for which a metallic syndesmotic screw was placed. Patients will be randomised to either
routine removal of the syndesmotic screw or removal on demand. Primary outcome is functional recovery at
12 months measured with the Olerud-Molander Score. Secondary outcomes are quality of life, pain and costs. In
total 194 patients will be needed to demonstrate non-inferiority between the two interventions at 80% power and
a significance level of 0.025 including 15% loss to follow-up.
Discussion: If removal on demand of the syndesmotic screw is non-inferior to routine removal in terms of functional
outcome, this will offer a strong argument to adopt this as standard practice of care. This means that patients will not
have to undergo a secondary procedure, leading to less complications and subsequent lower costs.
Trial registration: This study was registered at the Netherlands Trial Register (NTR5965), Clinicaltrials.gov
(NCT02896998) on July 15th 2016.
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Background
Ankle fractures are among the most common fractures. It
is estimated that the incidence of ankle fractures ranges
from about 25,000 in the Netherlands to more than five
million people in the United States annually and the inci-
dence is rising [1, 2]. Both young and elderly people are at
risk for these fractures. In general, younger people are
more at risk as a result of a more active lifestyle and eld-
erly people because of poorer bone quality [3, 4]. Approxi-
mately half of the patients with an ankle fracture require
surgical treatment because of joint instability. In approxi-
mately 20% of these fractures there is a concomitant injury
of the syndesmosis and syndesmotic repair is indi-
cated [5]. After anatomical reduction a syndesmotic
‘positioning screw’ is placed through the fibula into
the tibia to maintain this reduction and allow the
syndesmotic ligaments to heal. Extensive research has
been conducted regarding the technical aspects of the
placement of the syndesmotic screw. For example, the
number of screws, their diameter, the level of place-
ment and whether they should engage three or four
cortices have been investigated thoroughly [6–10].
After a period of 8 – 10 weeks the syndesmosis will
generally be healed and the screw will lose its func-
tion. It is an ongoing discussion whether the syndes-
motic screw needs to be removed subsequently. Most
surgeons advocate its removal because of suspected
impaired range of motion and chance of breakage of
the screw [9, 11–13]. During normal ambulation the
fibula moves and the syndesmosis widens [14, 15].
The positioning screw is thought to restrict this
movement and the screw is therefore removed. How-
ever, several case series have shown similar outcomes
in patients in which the syndesmotic screw was
retained compared to patients in whom the syndes-
motic screw was removed [16–18]. The positioning
screw is most likely not causing complaints in pa-
tients with retained screws because of loosening or
breakage of the screw [16, 17, 19, 20]. In a recent
systematic review there seemed to be no significant
difference in functional outcome between patients
undergoing routine removal and patients in whom
the syndesmotic screw was only removed in case of
symptomatic implants. [21] However, this was only
based on one underpowered RCT and several low
quality case-series and therefore high-quality evidence
on this subject is desirable.
We therefore initiated a randomized controlled trial in
which we aim to investigate the effect of ‘removal of de-
mand’ of the syndesmotic screw(s) compared to ‘routine re-
moval’ on functional outcome. Furthermore we will
investigate the economic effect of leaving the syndesmotic
screw(s) in place.
Design
This pragmatic international multicentre randomised
controlled trial will randomise between routine- and on
demand removal of the syndesmotic screw(s) after place-
ment for a traumatic syndesmotic injury (both isolated
syndesmotic injuries and concomitant syndesmotic in-
juries in ankle fractures). Both teaching and non-
teaching hospitals will participate in this study including
three academic Level 1 trauma centres in Europe. An
overview of participating centres is shown in Table 1.
Participants
The eligible study population will consist of consecutive
adult patients with a traumatic syndesmotic injury.
Inclusion criteria
 Placement of one or two metallic syndesmotic
screw(s) for an unstable ankle fracture with a
syndesmotic injury or an isolated syndesmotic injury
 Syndesmotic screw(s) placed within 2 weeks of the
trauma
 Physical condition allows the patient to undergo an
elective second procedure (i.e. removal of the screw)
Exclusion criteria
 ISS score > 15
 Injuries to the ipsi- and contralateral side which may
hamper rehabilitation
 Other medical conditions which hamper physical
rehabilitation (i.e. musculoskeletal disabilities or
severe psychological conditions)
Table 1 Participating centres
Academic Medical Centrea Amsterdam, the Netherlands
Bovenij Hospital Amsterdam, the Netherlands
Catharina Hospital Eindhoven, the Netherlands
Deventer Hospital Deventer, the Netherlands
Flevo Hospital Almere, the Netherlands
Haaglanden MC The Hague, the Netherlands
Helsinki University Hospitala Helsinki, Finland
Jeroen Bosch Hospital ‘s-Hertogenbosch, the Netherlands
Maasstad Hospital Rotterdam, the Netherlands
Noordwest Hospital Group Alkmaar, the Netherlands
OLVG Amsterdam, the Netherlands
Slotervaart Hospital Amsterdam, the Netherlands
Spaarne Hospital Amsterdam, the Netherlands
VU University Medical Centrea Amsterdam, the Netherlands
Westfries Hospital Hoorn, the Netherlands
alevel 1 trauma centres
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 Insufficient understanding of the Dutch or English
language
Interventions
Patients will be informed about the study by their treat-
ing physician following the procedure in which the syn-
desmotic screw was placed. After this, patients are
contacted by the coordinating investigator to request
participation in the study. After obtaining signed in-
formed consent patients will be randomly assigned in a
1:1 allocation ratio to one of the following groups:
1) Control group: Routine removal of the syndesmotic
screw(s) 8 – 12 weeks following the index procedure
or
2) Intervention group: On demand removal of the
syndesmotic screw(s)
Patients in the control group will undergo routine re-
moval of the syndesmotic screw 8 – 12 weeks post-
operatively (according to the preference of the treating
surgeon). Patients will not undergo routine removal in
case of 1) a contra-indication for undergoing a second
procedure for example due to a (new) medical condition
or 2) explicit request of the patient after consultation of
their treating surgeon. In the intervention group the
screw will only be removed in case of symptomatic im-
plants, defined as: 1) implants causing pain, 2) implants
(suspected of ) causing restricted range-of-motion 3) ex-
plicit request of the patient 4) an infection or 5) other
problems related to the screw such as protruding screw-
head. The screw will only be removed after a consult-
ation of the treating surgeon (except in patients who
wish to no longer participate in the study). In patients in
the control group in whom the syndesmotic screw
brakes prior to planned removal, the screw will be left in
place and only removed in case of symptoms.
Study procedures
This study is a pragmatic trial, which implies physicians
are allowed to follow local guidelines concerning the
treatment of these injuries apart from the intervention
investigated. Participating centres are however informed
that the preferred surgical technique is a tricortical
3.5 mm diameter screw between 2 and 4 cm of the pilon.
If a large reduction clamp is used, the preferred tech-
nique is the use of a temporary K-wire as ‘glide path’
[22]. Besides this, participating centres are allowed to
choose their own postoperative treatment routine: for
example in the use of a cast, non-weight bearing regime
and timing of syndesmotic screw removal (within the
predefined time window). At 3 months following the
index procedure, patients are assessed at the outpatient
clinic. Patients are instructed to visit the outpatient
clinic sooner in case of any signs of a POWI: warmth,
redness, pain, drainage or a fever above 38.5 degrees
Celsius. During the visit to the outpatient clinic the pa-
tients are seen by their treating physician and the coord-
inating investigator. The coordinating investigator will
document signs of POWI and will determine its pres-
ence or any special findings on physical examination.
Furthermore patients are requested to fill out several
questionnaires (Table 1). At the six and 12 months
follow-up, patients are requested to fill out the same
questionnaires and the range-of-motion is measured.
Follow-up will take place within a window of 2 weeks of
the projected follow-up moment.
Randomisation
Randomisation will be stratified by centre and age cat-
egory (i.e. ≥ 60 years and < 60 years). Randomisation will
be blocked within strata. Randomisation sequence is
generated by a dedicated computer randomisation soft-
ware program (CASTOR®, Amsterdam, The
Netherlands), ensuring allocation concealment. Random-
isation will mostly be performed at the outpatient clinic
by coordinating investigator using a dedicated, password
protected, SSL–encrypted website.
Primary Outcome
The primary outcome parameter is functional outcome
12 months following the index procedure measured with
the Olerud-Molander ankle score (OMAS) (Table 2).
To be able to assess the Minimally Clinical Important
Difference of the OMAS, anchor questions will be added
to the OMAS at six and 12 months as described by
Walenkamp et al. [23].
Secondary outcomes
Secondary outcome measures of the study are:
 Functional outcome with the American Orthopedic
Foot and Ankle Hindfoot Score (AOFAS) [24]
 Pain as measured by a ten-point Visual Analog
Scale.
 Range of motion, both absolute and as a percentage
compared with the uninjured side.
 Postoperative wound infections classified using the
criteria as defined by The Centers for Disease
Control and Prevention (CDC-criteria) [25]
 Synostosis or recurrent diastasis (as seen on
radiographs made in case of symptoms)
 Health-related quality of life as measured by the EQ-
5D-5 L questionnaire [26].
 Health care resources utilization (including amongst
others; number of visits to the general practitioner
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and use of home care organizations) as measured by
way of a combination of the Dutch/English iMTA
Medical Consumption Questionnaire (iMCQ) and
iMTA Productivity Cost Questionnaire (iPCQ) (only
applicable for the Dutch study population).
 Costs (economic evaluation including budget impact
analysis): the economic evaluation of the RODEO-
trial will be performed as a cost-effectiveness (CEA)
as well as a cost-utility (CUA) analysis (only applic-
able for the Dutch study population).
Furthermore general demographics will be assessed
such as age, gender, body mass index, co-morbidities,
American Society of Anesthesiologists (ASA) classifica-
tion, substance abuse, level of activity, bone mineral
density (when available), fracture characteristics, surgical
characteristics, duration of non-weight bearing period
and use of physiotherapy.
Sample size
We based our sample size calculation on a non-
inferiority design. The Olerud-Molander score (OMAS)
will serve as primary outcome measure. We have used
the results from an earlier study on this subject for our
sample size calculation [27]. For the sample size calcula-
tion we hypothesized an equal OMAS between the two
groups. Using a one-sided significance level (α) of 0.025
and a power (ß) of 90% with a standard deviation (SD)
of 19 points (derived from the study mentioned before)
and setting our non-inferiority limit at 10 a total of 76
patients are needed in each study arm. Taking a 10% loss
to follow-up into account, a total number of 167 sub-
jects will be needed to demonstrate non-inferiority be-
tween the two treatment strategies. Furthermore we
performed a sample size calculation for a subgroup ana-
lysis based on age. We hypothesize that the SD will be
lower in these subgroups due to increased homogeneity,
therefore we have used an SD of 16 for the sample size
calculation of the subgroups. Using a significance level
(α) of 0.05 and a power (ß) of 90% 88 patients are
needed in each subgroup to prove non-inferiority. Tak-
ing 10% loss to follow-up into account a total of 193 pa-
tients need to be randomized.
Statistical analysis
The primary endpoint will be analysed according to the
intention-to-treat and the per-protocol principle, non-
inferiority will only be declared if both types of analysis
prove non-inferiority. The primary endpoint will be ana-
lysed using a one sided test for non-inferiority with an
alpha of 0.025. Descriptive methods will be used to as-
sess quality of data, homogeneity of treatment groups
and endpoints. Normality of the data will be analysed by
visually inspecting the histograms. Secondary outcomes
will be analysed using either a t-test or Mann-Whitney
U test for continuous data according to the distributing
of the data and a Chi Square test for categorical data.
Missing data will be handled through multiple imput-
ation with predictive mean matching. All analyses will
be performed using the standard statistical software.
Table 2 Time table and follow-up schedule
RODEO-trial Enrollment Randomization /
Allocation
Follow-up
TIMEPOINT Post-
operatively
8 – 12 weeks
post-operatively
3 months
Post-operatively
6 months
Post-operatively
12 months
Post-operatively
Enrollment
Eligibility screening X
Informed Consent X
Intervention
Removal of syndesmotic screw (according to
randomization)
X
Assessment
Plain radiographs X X
OMAS X X X
Visual analogue pain scale (VAS) X X X
Range-of-Motion X X X
POWI X
AOFAS X X X
EQ-5D-5 L X X X
i-MCQ X X X
i-PCQ X X X
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Separate analyses will be performed on subgroups based
on age. A multivariable analysis will be performed to
identify predictors of worse functional outcome.
The CEA and CUA will be performed on the intention
to treat data, with a time horizon of 12 months and from
a societal perspective. The primary economic outcomes
are the costs per quality adjusted life year (QALY) and
the costs per point functional recovery improvement.
Moreover a budget impact analysis (BIA) will be per-
formed with a time horizon of 4 years. The question-
naires estimating the secondary outcome measures
‘resources utilization’ and ‘costs’ will only be used in pa-
tients included in the Netherlands due to practical feasi-
bility and to ensure a valid outcome.
Recruitment and consent
The patient will be informed about the RODEO-trial fol-
lowing placement of a syndesmotic screw or when he or
she visits the outpatient clinic following surgery and is
provided with the patient information letter. Patients
will have a minimum of 2 days to decide whether they
want to participate or not in the study. For patients re-
cruited directly postoperatively this means they can be
included upon their first visit at the outpatient clinic.
For patients who are informed for the first time at the
outpatient clinic the coordinating investigator will con-
tact them by phone (if the patient agrees to be contacted
by phone by the coordinating investigator). Randomisa-
tion will take place after they have returned the signed
informed consent forms.
Benefits and risks assessment, group relatedness
A recent systematic review suggests that our interven-
tion is safe and has similar functional outcome com-
pared to the routine removal [21]. Subjects will not
undergo additional investigations and interventions due
to participation in the RODEO-trial and therefore risks
to subjects involved in this trial are at least similar to
current practice. Potential benefits for subjects in the in-
vestigational treatment arm could be a lower risk of sur-
gical site infections and not having to undergo a
secondary procedure.
Indemnities
The institutional review board at the AMC has waived
liability insurance, because no additional risk can be at-
tributed to participation in this study.
Publication plan
The principal investigator, the study designer and the
study coordinator will be named author. All others will
obtain group authorship in the study group. All authors
including group members are allowed to present the re-
sults after approval of the principle investigator.
Discussion
Displayed above is the protocol for an adequately pow-
ered study investigating the difference in routine re-
moval versus removal on demand of the syndesmotic
screw in ankle injuries. This will be the first RCT able to
prove whether a statistically significant and clinically
relevant difference exists.
Since this is a pragmatic trial, surgeons are allowed to
choose their own postoperative treatment routine. This,
combined with the 15 participating centres will result in
a variation in for example the use of a cast, the duration
of non-weight bearing mobilisation and a minor vari-
ation in the timing of the removal of the syndesmotic
screw. However, we believe that this situation accurately
reflects daily practice, considering that slight variations
in post-operative treatment regimens are inevitable.
The inclusion of the University Hospital Helsinki
makes this trial international. This greatly improves the
external validity of the trial. Not all secondary outcome
measures can be used in an international setting. The
budget impact analysis and the health care resources
utilization for example can only be used for patients in
the Netherlands. This is due to practical feasibility but
also to ensure a valid outcome. When the same (trans-
lated) questionnaire would be used in patients in
Finland, results would not be extractable since the costs
of healthcare (e.g. a surgical procedure or a visit to the
physiotherapist) will not likely be the same as in the
Netherlands. However, the participation of a hospital
outside of the Netherlands will give us more insight in
how to implement the results not just in the
Netherlands, but in the rest of Europe as well.
If this trial proves that removal on demand is indeed
non-inferior to routine removal of the syndesmotic
screw(s) in terms of functional outcome, this will offer a
strong argument to adopt this as standard practice of
care. It would mean that patients will not have to
undergo a secondary procedure, leading to less compli-
cations and subsequent lower costs.
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